Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 447-920-2 | CAS number: 897393-42-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-01-05 - 2009-02-13
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.31 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3700 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Details on test material:
- Identification: XTJ-568 dihydrochloride
Molecular formule: C10H26Cl2N2O2 (component A) C14H34Cl2N2O3 (component B)
Molecular weight: 277.23 (component A) 349.34 (component B)
Description: Clear yellow liquid (determined at NOTOX)
Batch: 8666-080-C
Purity: ~ 100%
Composition: This product consists essentially of two components, derived from the reaction of ethylene glycol and butylene oxide in ratios of 2/1 and 3/1. The 2/1 adduct (component A) is approximately 80% of the mixture and the 3/1 adduct (component B) is approximately 20%.
The concentration of the salt in this solution is 70.5%.
Test substance storage: At room temperature in the dark
Stability under storage conditions: Stable
Expiry date: 15 June 2009
Constituent 1
- Specific details on test material used for the study:
- - Identification: XTJ-568 dihydrochloride
- Molecular formule: C10H26Cl2N2O2 (component A) C14H34Cl2N2O3 (component B)
- Molecular weight: 277.23 (component A) 349.34 (component B)
- Description: Clear yellow liquid (determined at NOTOX)
- Batch: 8666-080-C
- Purity: ~ 100%
- Composition: This product consists essentially of two components, derived from the reaction of ethylene glycol and butylene oxide in ratios of 2/1 and 3/1. The 2/1 adduct (component A) is approximately 80% of the mixture and the 3/1 adduct (component B) is approximately 20%. The concentration of the salt in this solution is 70.5%.
- Test substance storage: At room temperature in the dark
- Stability under storage conditions: Stable
- Expiry date: 15 June 2009
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Rat Crl:WI(Han) (outbred, SPF-Quality) from Charles River, Sulzfeld, Germany
- Age at study initiation: Age at start of pairing: approximately 12 weeks. Females were nulliparous and non-pregnant at initiation of the study. Stock male rats Crl:WI(Han) (outbred, SPF-Quality) were used for mating with the females. After mating these males were placed back in their stock and might be used in further studies.
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing:
* Pre-mating: During acclimatization, females were housed in groups of 5 animals/cage in Macrolon cages (MIV type, height 18 cm). Acclimatization period was at least 5 days prior to pairing under laboratory conditions.
* Mating: Females were caged together with males on a one-to-one-basis in Macrolon cages (MIII type, height 18 cm). During the weekend, mating procedures were suspended and the animals were housed in groups of maximum 5 animals/sex/cage in Macrolon cages (MIV type, height 18 cm).
* Post-coitum: Females were individually housed in Macrolon cages (MIII type, height 18 cm).
* Randomization: Upon detection of mating (Day 0 post-coitum), the females were distributed in a random sequence over the test groups. Females which were mated on the same day were classified in the same subgroup.
* General: Sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France) and paper as cage-enrichment (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied. Certificates of analysis were examined and then retained in the NOTOX archives.
- Diet (e.g. ad libitum): Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany). Results of analyses for nutrients and contaminants of each batch were examined and archived.
- Water (e.g. ad libitum): Free access to tap-water. Certificates of analysis (performed quarterly) were examined and archived.
- Acclimation period: No data
Analysis of bedding, paper, diet and water did not reveal any findings that were considered to have affected study integrity.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21±3ºC (actual range: 18.6-22.8ºC)
- Humidity (%): 30-70% (actual range: 22-66%)
- Air changes (per hr): approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hour light/12 hour dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- Vehicle:
Water (Elix, Millipore S.A.S., Molsheim, France)
Rationale for vehicle: Based on information provided by the sponsor and trial formulations performed at NOTOX.
Stability of test substance in vehicle: At least 8 days, if stored in the refrigerator (determined as part of NOTOX Project 489273).
Method of formulation: Formulations (w/w) were prepared weekly and were homogenised to a visually acceptable level. Adjustment was made for density of the test substance (1.106 g/mL).
Storage conditions: In the refrigerator.
Dose volume:
5 mL/kg body weight. Actual dose volumes were calculated according to the latest body weight.
Concentrations of formulations:
0, 30, 90 and 200 mg/mL. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analyses were done on one day during the treatment period according to a validated method (NOTOX Project 489272) as specified below.
Group Analysis (type of sample)
1 acc (M)
2 acc + hom (TMB)
3 acc (M)
4 acc + hom (TMB)
Duplicate samples were analyzed
acc=accuracy, hom=homogeneity, T=top, M=middle, B=bottom position of container
The accuracy of preparation was considered acceptable if the mean measured concentrations were 90-110% of the target concentration for solutions. Homogeneity was demonstrated if the coefficient of variation was 10%.
Results:
The concentrations analysed in the formulations of Group 2, Group 3 and Group 4 were in agreement with target concentrations (i.e. mean accuracies between 90% and 110%).
A small response at the retention time of the test substance was observed in the chromatograms of the Group 1 formulation. The maximum contribution based on area to the Group 2 samples was 1.2%. The source for the response in Group 1 is probably due to carry-over of the analytical method, as no analytical column is used. Due to the nature of the test substance, this could not be circumvented.
The formulations of Group 2 and Group 4 were homogeneous (i.e. coefficient of variation 10%). - Details on mating procedure:
- Age at start of pairing: approximately 12 weeks
Breeding procedures:
One female was placed on a one-to-one-basis in the cage of a male rat. Detection of mating was confirmed by evidence of sperm in the vaginal lavage or by the appearance of an intravaginal copulatory plug. This day was designated Day 0 post-coitum. Once mating had occurred, the female was separated from the male. When sufficient mated females had been obtained for each dose group, the surplus females were removed from the study. - Duration of treatment / exposure:
- From Day 6 to Day 19 post-coitum, inclusive
- Frequency of treatment:
- Once daily for 7 days per week, approximately the same time each day with a maximum of 6 hours difference between the earliest and latest dose.
- Duration of test:
- 20 days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 150 mg/kg bw/day (nominal)
- Dose / conc.:
- 450 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 24 females/sex/dose
- Control animals:
- yes, concurrent vehicle
Examinations
- Maternal examinations:
- Mortality / Viability
At least twice daily.
Clinical signs
At least once daily from Day 0 post-coitum onwards. The time of onset, degree and duration was recorded. All symptoms were graded according to fixed scales: Maximum grade 1: grade 0 = absent, grade 1 = present.
Maximum grade 3 or 4: grade 1 = slight, grade 2 = moderate, grade 3 = severe, grade 4 = very severe.
Examination of cage debris of pregnant females revealed no signs of abortion or premature birth. No signs of difficult or prolonged parturition were noted among the pregnant females.
Body weights
Days 0, 3 and 6-20 (daily) post-coitum.
Food consumption
Days 0-3, 3-6, 6-9, 9-12, 12-15, 15-17 and 17-20 post-coitum.
Water consumption
Subjective appraisal was maintained during the study, but no quantitative investigation was introduced as no effect was suspected. - Ovaries and uterine content:
- All animals were subjected to an examination post-mortem. All animals surviving to Day 20 post-coitum were sacrificed using an oxygen/carbon dioxide procedure. External, thoracic and abdominal examinations were performed for the detection of macroscopic abnormalities. All abnormalities were collected and fixed in 10% buffered formalin (neutral phosphate buffered 4% formaldehyde solution, Klinipath, Duiven, The Netherlands).
Each ovary and uterine horn of animals surviving to planned necropsy was dissected and examined as quickly as possible to determine:
- The number of corpora lutea.
- The weight of the gravid uterus.
- The number and distribution of live and dead fetuses.
- The number and distribution of embryo-fetal deaths.
- The weight of each fetus.
- The sex of each fetus from the ano-genital distance (during necropsy)
and also from gonadal inspections (during further fetal examination).
- Externally visible macroscopic fetal abnormalities.
In case a female was not pregnant, the uterus was stained using the Salewski technique (Salewski, 1964) in order to determine any former implantation sites (Salewski staining prepared at NOTOX using Ammoniumsulfide-solution 20% (Merck, Darmstadt, Germany) and Milli-Ro water (Millipore Corporation, Bedford, USA)).
The female genital tract including the placentas was preserved in 10% buffered formalin for possible histopathological examination. - Fetal examinations:
- External, visceral and skeletal fetal findings were recorded as developmental variations or malformations.
External:
Each viable fetus was examined in detail, sexed and weighed. All live fetuses were euthanized by subcutaneous injection of 0.01 mL pentobarbital (Euthesate®; Ceva Sante Animale B.V., Maassluis, The Netherlands for necropsies before 01 February 2009; Euthasol® 20%; AST Farma B.V., Oudewater, The Netherlands for necropsies from 01 February 2009 onwards) in the area between the scapulas. Nonviable fetuses (the degree of autolysis was minimal or absent) were examined, crown-rump length measured, weighed and sexed. The crown-rump length of late resorptions (advanced degree of autolysis) was measured, the degree of autolysis recorded, a gross external examination performed and the tissue was discarded.
Subsequently, each litter was divided into two groups:
- Approximately one half of the fetuses in each litter was examined for visceral anomalies (for details see below).
- The remaining half of the fetuses in each litter was used for skeletal examination (for details see below).
Visceral (Internal):
Approximately one-half of the fetuses in each litter was examined for visceral anomalies by dissection in the fresh (non-fixed) state. The thoracic and abdominal cavities were opened and dissected using a technique described by Stuckhardt and Poppe (Stuckhardt, 1984). This examination included the heart and major vessels. The sex of all fetuses was confirmed by internal examination.
The heads of these fetuses were removed and placed in Bouin's solution (Klinipath, Duiven, The Netherlands) for subsequent processing and soft-tissue examination using the Wilson sectioning technique (Wilson, 1965). After examination, the tissues were stored in 10% buffered formaline.
The carcasses were eviscerated and stored in identified containers containing 96% aqueous alcohol (Klinipath, Duiven, The Netherlands) without further examinations.
Skeletal:
Following confirmation of the sex by internal examination, the carcasses of the remaining half of the fetuses in each litter were eviscerated and fixed in identified containers containing 96% aqueous ethanol (Klinipath, Duiven, The Netherlands) for subsequent examination of skeletons.
Following fixation in alcohol, all fetuses were macerated in potassium hydroxide (Merck, Darmstadt, Germany) and stained with Alizarin Red S (Klinipath, Duiven, The Netherlands) by a method similar to that described by Dawson (Dawson, 1926). For the selected fetuses, the skeletal examination was performed. The specimens were archived in glycerin (Klinipath, Duiven, The Netherlands) with bronopol (Merck, Darmstadt, Germany) as preservative. - Statistics:
- The following statistical methods were used to analyze the data:
- If the variables could be assumed to follow a normal distribution, the Dunnett-test (Dunnett, 1955) (many-to-one t-test) based on a pooled variance estimate was applied for the comparison of the treated groups and the control groups for each sex.
- The Steel-test (Miller, 1981) (many-to-one rank test) was applied if the data could not be assumed to follow a normal distribution.
- The Fisher Exact-test (Fisher 1950) was applied to frequency data.
Mean litter proportions (percent per litter) of total fetal malformations and developmental variations (external, visceral, skeletal and combined), and each particular external, visceral and skeletal malformation or variation were subjected to the Kruskal-Wallis nonparametric ANOVA test (Kruskal and Wallis 1952) to determine intergroup differences. If the ANOVA revealed statistically significant (p<0.05) intergroup variance, Dunn¿s test (Dunn 1964) was used to compare the compound-treated groups to the control group.
All tests were two-sided and in all cases p < 0.05 was accepted as the lowest level of significance.
The following definitions were applicable for implantation data:
- Fetal (late) resorptions were defined as a dead fetus with external degenerative changes and presence of distinguishable features such as head or limbs.
- Embryonic (early) resorptions were defined as evidence of implantation without presence of distinguishable features such as head or limbs.
- Post-implantation loss included embryonic (early) resorptions, fetal (late) resorptions and dead fetuses. - Historical control data:
- Yes, available
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- At 1000 mg/kg bw/day, slight body weight loss occurred during the first two days of treatment. Lower body weights and body weight gain as compared to controls were noted from the second day of treatment onwards. In addition, (for uterus weight) corrected body weight gain was statistically significantly decreased for the high dose group as compared to control animals.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- At 1000 mg/kg, a lower food intake (before and after allowance for body weight) as compared to the control group was recorded during the whole treatment period (not always statistically significant). Effects were most pronounced in the first week of treatment.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not specified
Maternal developmental toxicity
- Number of abortions:
- no effects observed
- Pre- and post-implantation loss:
- no effects observed
- Total litter losses by resorption:
- no effects observed
- Early or late resorptions:
- no effects observed
- Dead fetuses:
- no effects observed
- Changes in pregnancy duration:
- no effects observed
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): no effects observed - Changes in number of pregnant:
- no effects observed
- Other effects:
- not specified
Effect levels (maternal animals)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- maternal toxicity
- Effect level:
- 450 mg/kg bw/day
- Basis for effect level:
- body weight and weight gain
- other: based on reduced body weights and body weight gain of the high dose animals at 1000 mg/kg/day
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- developmental toxicity
- Effect level:
- > 1 000 mg/kg bw/day
- Basis for effect level:
- other: In the absence of treatment-related effects on reproductive parameters, fetal body weight and fetal morphology, a dosage level of 1000 mg/kg/day was considered to be the NOAEL for developmental toxicity.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Maternal abnormalities
- Key result
- Abnormalities:
- no effects observed
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Fetal/pup body weight changes" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.FetalPupBodyWeightChanges): no effects observed - Reduction in number of live offspring:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- no effects observed
- Changes in postnatal survival:
- no effects observed
- External malformations:
- no effects observed
- Skeletal malformations:
- no effects observed
- Visceral malformations:
- no effects observed
- Other effects:
- not specified
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- embryotoxicity
- Effect level:
- > 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Fetal abnormalities
- Key result
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Key result
- Developmental effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- Based on the results in this prenatal developmental toxicity study, the maternal No Observed Adverse Effect Level (NOAEL) for the test substance was established as being 450 mg/kg/day, based on reduced body weights and body weight gain of the high dose animals at 1000 mg/kg/day. In the absence of treatment-related effects on reproductive parameters, fetal body weight and fetal morphology, a dosage level of 1000 mg/kg/day was considered to be the NOAEL for developmental toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Παρόλο που ο Οργανισμός παρέχει μεγάλο μέρος του διαδικτυακού περιεχομένου στη γλώσσα σας, ένα μέρος αυτής της σελίδας είναι μόνο στα αγγλικά. Περαιτέρω πληροφορίες για την πολύγλωσση πρακτική του ECHA.
Καλώς ήρθατε στον δικτυακό τόπο του ECHA. Η παρούσα ιστοθέση δεν υποστηρίζεται πλήρως από τον Internet Explorer 7 (ή προγενέστερες εκδόσεις). Αναβαθμίστε τον φυλλομετρητή σας Internet Explorer σε πιο πρόσφατη έκδοση.
Ο παρών ιστότοπος χρησιμοποιεί cookies για να διασφαλίζεται ότι αποκομίζετε την καλύτερη δυνατή εμπειρία από την περιήγησή σας στους ιστοτόπους μας.
Μάθετε περισσότερα σχετικά με τον τρόπο που χρησιμοποιούμε τα cookies.